Foresight Diagnostics
Executivos
Veja o organograma con seus 12 executivos principais
Biografias mais buscadas da Foresight Diagnostics
- Jake Chabon, Chief Executive Officer and Chief Scientific Officer
- Mark Lee, Board Member
- Shahram Seyedin-Noor, Director
Recentes movimentos de executivos em Foresight Diagnostics
- John Truesdell, ingressou na Companhia como Chief Business Officer (Notícia publicada em 18 de agosto de 2023).
Criar um alerta
para seguir os movimentos de executivos da Foresight Diagnostics.
Biotecnologia
Foresight Diagnostics possui 2.290 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Aardvark Therapeutics acaba de anunciar uma arrecadação de fundos de 85 milhões de dólares. (publicado em 12 de maio de 2024).
- Bluejay Therapeutics acaba de anunciar uma arrecadação de fundos de 182 milhões de dólares. (publicado em 12 de maio de 2024).
- Delphia Therapeutics acaba de anunciar uma arrecadação de fundos de 67 milhões de dólares. (publicado em 7 de maio de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Foresight Diagnostics
- Foresight Diagnostic’s Co-Founder Dr. David Kurtz Joins Company as Chief Medical Officer and Head of Research
- Allogene Therapeutics, Foresight Diagnostics Partner to Develop MRD Test for CAR T-Cell Therapy Trial
- Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma (LBCL)
- Foresight Diagnostics and partners present twelve studies demonstrating accuracy and utility of PhasED-Seq ctDNA platform for early response assessment at the 65th American Society of Hematology (ASH) Annual Meeting
- Foresight Diagnostics Presents Four Presentations and Two Posters demonstrating accuracy and utility of PhasED-Seq ctDNA platform for early response assessment at the 65th American Society of Hematology (ASH) Annual Meeting
- Hodgkin lymphoma prognosis, biology tracked with circulating tumor DNA
- Foresight Diagnostics Announces Six Presentations Highlighting the Utility of PhasED-Seq™ for Early and Accurate MRD Detection at the 65th American Society of Hematology Annual Meeting
- Foresight Diagnostics Strengthens Leadership Team with Addition of Chief Business Officer John Truesdell
- Foresight Diagnostics Announces Study Demonstrating Prognostic Utility of PhasED-SeqTM for MRD Assessment after Frontline DLBCL Treatment at the 17th International Conference on Malignant Lymphoma
- View more press releases Close
Redes sociais sobre Foresight Diagnostics
- Foresight Diagnostics na Wikipedia, Google News e Yahoo Finance
- Foresight Diagnostics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Jake Chabon 
Ligue para a Foresight Diagnostics em +91 810...
